Fistula-in-ano in Infants and Children
1 other identifier
interventional
20
1 country
1
Brief Summary
In this prospective, randomized trail, duration of non-cutting seton placement in patients with fistula-in-ano is evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2022
CompletedFirst Posted
Study publicly available on registry
December 28, 2022
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
September 8, 2025
August 1, 2025
5 years
December 18, 2022
August 31, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Recurrent fistula in ano
6 months after initial surgery
Recurrent perianal abscess
6 months after initial surgery
Study Arms (2)
Group 4weeks
ACTIVE COMPARATORDuration of placed seton 4 weeks
Group 12weeks
ACTIVE COMPARATORDuration of placed seton 12 weeks
Interventions
Treatment of Fistula in ano is conducted according to the institution's treatment guidelines. Silicon seton placement is conducted under general anesthesia. Identification of the FIA is secured by the insertion of a bulb-headed lacrimal probe, on which a silicon vessel loop is attached and pulled through the entire fistulous tract. In case of a perianal abscess, drainage and sphincter-sparing debridement is performed followed by secondary wound healing. The loop is ligated loosely outside the anus without any additional tension to the skin. Duration of placed seton is depending on group assignment and is set to either 4 or 12 weeks.
Eligibility Criteria
You may qualify if:
- any patient with FIA and treatment with non-cutting seton placement in our institution
- regardless of underlying diagnoses
- age 0-18 years
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Friedrich-Alexander-Universität Erlangen-Nürnberg, Pediatric Surgery
Erlangen, Bavaria, 91054, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sonja Diez, MD
Friedrich-Alexander-Universität Erlangen-Nürnberg
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Masking is not possible due to study design.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
December 18, 2022
First Posted
December 28, 2022
Study Start
January 1, 2023
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
September 8, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share